TABLE 4:

Final diagnosis, treatment schedule and changes in systolic blood pressure over time in the five cases presented 

PatientDiagnosisPretreatment
(SBP mmHg)
Post-treatment
(SBP mmHg)
Benazepril
(0.25 mg/kg twice a day)
Benazepril + amlodipine
(0.25 mg/kg twice a day +
0.2 mg/kg once a day)
Telmisartan + amlodipine
(1 mg/kg twice a day +
0.2 mg/kg once a day)
Follow-up
Case 1
Miniature Schnauzer, female, 8 years, 7.8 kg
Idiopathic SHT with TOD190180
(month 4)
170
(week 2)
160
(week 2)
120 (±10)
(8 months)
Case 2
Cocker spaniel, female, 12 years, 10.9 kg
SHT +
mammary carcinoma +
CMVD stage B1 + CKD IRIS 1
180220
(month 1)
170
(month 4)
150
(week 2)
130 (±5)
(month 2)
Case 3
Mongrel, female, 14 years, 7 kg
SHT + CMVD stage B2 + CKD IRIS 2240210
(week 1)
200*
(0.3 mg/kg ADP week 1)
140*
*(0.3 mg/kg ADP week 1)
150 (±5)
(month 5)
Case 4
Miniature Schnauzer, male, 10 years, 8 kg
SHT + CMVD stage B2 + CKD IRIS 2220190
(week 3)
200
(month 2.5)
160*
*(0.4 mg/kg ADP week 2)
160 (±15)
(months 1–5)
Case 5
American cocker spaniel, male, 14 years, 15 kg
SHT + CMVD stage B + unclassified tumours in bladder and right testicle240190
(week 3)
180
(week 2)
165*
*(0.4 mg/kg ADP week 2)
165 (±15)
(months 1–6)
  • ADP, amlodipine; CKD, chronic kidney disease; CMVD, chronic mitral valve disease; IRIS, International Renal Interest Society; SBP, systolic blood pressure; SHT, systemic hypertension; TOD, target organ damage.

  • * Sistolic blood pressure achieved with the dose of amlodipine showed in brackets